Ultimately, integrating multimodal biomarkerscombining neuroimaging, electrophysiology (Cardon et al., 2020), blood-based molecular profiles, and audiological measuresinto a composite model holds the greatest promise
Its a secondary benefit stemming from a dramatic improvement in overall well-being
As a proxy for Medicare insurance, we segmented initiation rate by populations aged 65 and older versus those aged 18-64
Market Scope Market Dynamics Drivers Burgeoning demand for potent metabolic therapies The rising cases of type 2 diabetes and obesity in Australia, growing trend of early diagnosis for timely interventions, changing lifestyles and the need for effective treatment strategies to lower the disease burden and improving patient health outcomes are boosting the demand for GLP-1 receptor agonists in Australia
Other states should follow the lead and basically require not just the revenue reporting, but also real accountability around how those revenues are being spent and whether patients are actually benefiting from it
Vitamin A for skin cell turnover
